New 'Gut Reset' Procedures Help Maintain Weight Loss
全新的「腸道重置」療程有助於維持減重成果
A significant medical breakthrough has emerged for those struggling with weight management: Duodenal Mucosal Resurfacing (DMR), often called a "gut reset."
一項重大的醫學突破為那些在體重管理上苦苦掙扎的人帶來了希望：十二指腸黏膜重塑術 (DMR)，通常被稱為「腸道重啟」。
For patients who discontinue GLP-1 medications like Ozempic, weight regain is common, affecting nearly 70% of individuals within 18 months.
對於停用像 Ozempic 這類 GLP-1 藥物的患者來說，體重反彈的情況很常見，近 70% 的人在 18 個月內會經歷這種情況。
This minimally invasive procedure uses controlled heat to resurface the lining of the duodenum, the small intestine's first section.
這種微創手術利用受控熱能來重塑十二指腸（小腸的第一部分）的內壁。
By removing damaged tissue caused by high-fat and high-sugar diets, the procedure aims to recalibrate metabolic signaling and hormone production.
通過清除由高脂肪和高糖飲食所造成的受損組織，該手術旨在重新校準代謝訊號和激素分泌。
Early trials, such as REMAIN-1, show promising results, with many participants maintaining over 80% of their weight loss after the procedure.
早期的試驗，如 REMAIN-1，顯示出令人期待的結果，許多參與者在手術後保持了超過 80% 的減重成果。
While DMR targets physical anatomy to restore metabolic balance, sustainable health improvements usually require long-term lifestyle habits like a fiber-rich diet and regular exercise.
雖然 DMR 通過目標性的身體解剖結構來恢復代謝平衡，但要獲得持久的健康改善，通常仍需長期的生活習慣，如富含纖維的飲食和規律運動。
Please note that DMR is currently an investigational treatment under rigorous study and is not yet a standard clinical procedure.
請注意，DMR 目前是一種正處於嚴格研究階段的試驗性治療，尚未成為標準的臨床程序。
As science evolves, this approach may one day provide a lasting way to stabilize weight without long-term pharmaceutical use.
隨著科學的演進，這種方法未來或許能提供一種無需長期依賴藥物即可穩定體重的長久途徑。
